(Q73793809)
Statements
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma (English)
J M Vose
D Colcher
L Gobar
P J Bierman
S Augustine
M Tempero
P Leichner
J C Lynch
D Goldenberg